Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kinjirushi Wasabi International USA is the North American subsidiary of Kinjirushi Co., Ltd., a Japanese pioneer in wasabi cultivation, processing, and functional research. Beyond its culinary wasabi products, the company focuses on the health and wellness benefits of wasabi-derived bioactive compounds, particularly hexaraphane (6-MSITC). Kinjirushi has conducted extensive joint industry-academia research demonstrating that its proprietary wasabi extract, Wasabi-sulfinyl®, supports cognitive health, memory enhancement, and antioxidant defense. The company commercially offers dietary supplements, such as Wasabi Sulfinyl Supplements, and bulk functional ingredients for the health, wellness, and cosmetics industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kinjirushi Wasabi International USA.